Your browser doesn't support javascript.
loading
Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases.
Lashgari, Naser-Aldin; Roudsari, Nazanin Momeni; Zadeh, Seyed Saeed Tamehri; Momtaz, Saeideh; Abbasifard, Mitra; Reiner, Zeljko; Abdolghaffari, Amir Hossein; Sahebkar, Amirhossein.
Afiliação
  • Lashgari NA; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Roudsari NM; Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
  • Zadeh SST; School of Medicine, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Momtaz S; Medicinal Plants Research Center, Institute of Medicinal Plants, ACECR, Tehran, Iran.
  • Abbasifard M; Toxicology and Diseases Group (TDG), The Institute of Pharmaceutical Sciences (TIPS), and Faculty of Pharmacy, Pharmaceutical Sciences Research Center (PSRC), Tehran University of Medical Sciences, Tehran, Iran.
  • Reiner Z; GI Pharmacology Interest Group (GPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Abdolghaffari AH; Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Sahebkar A; Department of Internal Medicine, Ali-Ibn Abi-Talib Hospital, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
Inflammopharmacology ; 31(1): 57-75, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36574095
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Doenças Neurodegenerativas Limite: Humans Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Doenças Neurodegenerativas Limite: Humans Idioma: En Revista: Inflammopharmacology Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã País de publicação: Suíça